Intellectual Property Portfolio
Geron protects its investments in new technologies through a carefully managed program of international intellectual property protection. Our patent portfolio covers innovations that arose from our internal research as well as technologies created in conjunction with collaborators and in-licensed patents.
Imetelstat is covered by multiple patent families including those relating to our proprietary nucleic acid chemistry and telomerase technologies. We developed imetelstat from inception and own exclusive worldwide commercial rights with U.S. patent coverage extending through 2025.